GoodRx Holdings (GDRX) Gross Profit (2019 - 2026)
GoodRx Holdings' Gross Profit history spans 7 years, with the latest figure at $390.1 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 394.42% to $390.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $739.3 million, a 73.86% increase, with the full-year FY2025 number at $739.3 million, up 73.86% from a year prior.
- Gross Profit hit $390.1 million in Q4 2025 for GoodRx Holdings, up from $112.5 million in the prior quarter.
- Over the last five years, Gross Profit for GDRX hit a ceiling of $390.1 million in Q4 2025 and a floor of -$132.5 million in Q4 2024.
- Historically, Gross Profit has averaged $135.4 million across 5 years, with a median of $118.3 million in 2025.
- Biggest five-year swings in Gross Profit: plummeted 228.78% in 2024 and later soared 394.42% in 2025.
- Tracing GDRX's Gross Profit over 5 years: stood at $106.8 million in 2021, then dropped by 6.35% to $100.0 million in 2022, then grew by 2.91% to $102.9 million in 2023, then plummeted by 228.78% to -$132.5 million in 2024, then soared by 394.42% to $390.1 million in 2025.
- Business Quant data shows Gross Profit for GDRX at $390.1 million in Q4 2025, $112.5 million in Q3 2025, and $118.2 million in Q2 2025.